Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Venture Capital
IDT Acquires Swift Biosciences
Life Sciences Times
-
March 12, 2021
0
Pharma
ViiV Healthcare presents positive proof-of-concept findings for a novel maturation inhibitor for the treatment of HIV
Life Sciences Times
-
March 9, 2021
0
Public Health
Has COVID Changed Spring Cleaning?
Life Sciences Times
-
March 9, 2021
0
Pharma
ReForm Biologics Announces the Issuance of Chinese Patent for Therapeutic Protein Formulations
Life Sciences Times
-
March 8, 2021
0
Biotech
LabVantage Adds Vendor Validation to Its Software-as-a-Service LIMS
Life Sciences Times
-
March 8, 2021
0
Pharma
IQVIA Collaborating with Janssen Research & Development on Their Investigational COVID-19 Vaccine Trials
Life Sciences Times
-
March 8, 2021
0
Life Sciences
New Research Reveals More CROs Taking Action to Meet Urgent Need for Faster Clinical Trials
Life Sciences Times
-
March 4, 2021
0
Pharma
Leading Sleep Medicine Expert Joins Apnimed Management Team
Life Sciences Times
-
March 4, 2021
0
Biotech
Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics
Life Sciences Times
-
March 2, 2021
0
Life Sciences
Saama Teams With Oracle to Offer Life Sciences Industry AI-Enabled Applications to Accelerate Clinical Trials
Life Sciences Times
-
March 1, 2021
0
1
...
776
777
778
...
805
Page 777 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026